Patients with MM and mouse models of MM commonly exhibit elevated levels of inflammatory cytokines, including TNF-α and IL-6, which are linked to disease onset, progression, symptom burden, and prognosis (103, 104). Here, IL6 is linked to Miyoshi myopathy.